three-dimensional brain images in preterm children with periventricular leukomalacia

Clicks: 73
ID: 174755
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #108 of 111 articles by views in regulatory toxicology and pharmacology : rtp

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
To investigate the use of three-dimensional (3D) brain magnetic resonance imaging (MRI) to evaluate in preterm children with periventricular leukomalacia. Materials and Methods: Semiautomated 3D classification of the gray and white tissues was used to reconstruct brain images of patients with confirmed periventricular leukomalacia from 2D MRI. Results: We studied 14 preterm patients. The gestational age ranged from 25–37 weeks. The corrected age ranged from 5–49 months. We reconstructed the gray matter, white matter, and ventricles in order to analyze the brain volume. Conclusion: Three-dimensional MRI is a good tool that can be used to demonstrate brain lesions in stereo and differentiate the gray matter, white matter, and ventricles. Brain volume can also be accurately evaluated.
Reference Key
chou2012pediatricsthree-dimensional Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Hsiao-Feng Chou;Ming-Fan Lin;Chia-Yuan Chen;Ein-Yiao Shen
Journal regulatory toxicology and pharmacology : rtp
Year 2012
DOI
10.1016/j.pedneo.2011.11.009
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.